Ireland· IE-PA-EU/1/13/862/001-006
Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
A indacaterol und glycopyrronium bromid product containing indacaterol maleate + glycopyrronium bromide, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Indacaterol und glycopyrronium bromid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL04 (indacaterol und glycopyrronium bromid), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Indacaterol und glycopyrronium bromid · ATC R03AL04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Indacaterol maleate + Glycopyrronium bromide
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- R03AL04
- ATC class
- Indacaterol und Glycopyrronium bromid
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/13/862/001-006
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol und glycopyrronium bromid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMIDIL COMBI AMIHALERZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- SwedenCopdalan 85 mikrogram/43 mikrogram Inhalationspulver, hård kapselG.L. Pharma GmbH
- FinlandIndacaterol/Glycopyrronium STADASTADA Arzneimittel AG
- United KingdomUltibro Breezhaler 85microgram/43microgram inhalation powder capsules with deviceNovartis Pharmaceuticals UK Ltd
- NorwayUltibro BreezhalerNovartis Europharm Limited (1)
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Indacaterol/Glycopyrronium Eg
- Czechia · Amidil Combi Amihaler
- Germany · Indacaterol/Glycopyrronium Al, Indacaterol/Glycopyrronium Stada
- Denmark · Copdalan, Indacaterol/Glycopyrronium Genetic
- Finland · Indacaterol/Glycopyrronium Stada
- France · Indacaterol/Glycopyrronium Axica Biogaran, Indacaterol/Glycopyrronium Rs01 Inhaler Arrow
- Greece · Indacaterol Glycopyrronium Stada, Libair
- Croatia · Indakaterol/Glikoprionij Stada
- Iceland · Plungymed, Ultibro Breezhaler
- Italy · Glindesia
- Liechtenstein · Ultibro Breezhaler, Ulunar Breezhaler
- Netherlands · Indacaterol Glycopyrronium Stada
- Norway · Indacaterol/Glycopyrronium Stada, Plungymed
- Poland · Amidil Combo Amihaler
- Portugal · Brometo De Glicopirrónio + Indacaterol Generis, Brometo De Glicopirrónio + Indacaterol Stada
- Sweden · Copdalan, Indacaterol/Glycopyrronium Polpharma
- Slovakia · Amidil Combi Amihaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8f06b31-9d23-4f77-8298-eae1d03cf493 GET /v1/drugs/c8f06b31-9d23-4f77-8298-eae1d03cf493?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalation powder, hard capsule",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"R03AL",
"R03AL04"
],
"strength": null,
"pa_number": "EU/1/13/862/001-006",
"substances": [
"Indacaterol maleate",
"Glycopyrronium bromide"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "19/09/2013",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about indacaterol und glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.